NewAmsterdam

Amsterdam, Netherlands · $196.0M raised

Headquarters
Amsterdam
Business Model
B2B
Total Funding
$196.0M
Last Round
$196.0M Series AJan 2021
Rounds
1

About

Clinical-stage biotechnology company developing transformative therapies for cardio-metabolic diseases.

Summary

NewAmsterdam is a SaaS company based in Amsterdam, Netherlands. It has raised $196.0M in total across 1 round, most recently a $196.0M Series A round in Jan 2021. Investors include Forbion Capital Partners and Morningside Group.

Tech & App Stack

2 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors

Similar Companies